ASIC approves C3 name change

By Dylan Bushell-Embling
Tuesday, 17 June, 2008

The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.

The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.

Overuse of inhalers can increase heart attack risk

Overuse of reliever inhalers is associated with higher risks of developing and dying from...

Unhealthy Western diet could accelerate cognitive decline

An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...

Cancer drug enters clinical trials based on a false mechanism

A cancer drug currently being tested in patients appears to have entered clinical trials based on...

Content from other channels on our network

Bottling line for resealable aluminium beverages

Allied Pinnacle invests $10m in Sydney manufacturing capacity

AI and robotic advances to be showcased at APPEX 2027

AFGC welcomes Domestic Gas Reservation Bill

Beverage facility built to keep the good times rolling

APPEX 2027 to put AI and robotic advances in the spotlight

Sparc and Levidian partner on UAE graphene‍-‍based coatings manufacturing

The roles of the vendor and EPCs in the project bidding process

ARC awards $82.5m for new research hubs and training centres

Industrial electricity costs could halve by sharing infrastructure

A Day in the Life of a rural generalist anaesthetist and men's mental health advocate

Government to commission aged care assessment tool review

Services commence today at Flinders Street Health

Burnout in health care isn't an 80/20 problem: why a more balanced view is needed and what it means for you and your workplace

A Good Cleaning Schedule: Best Practices for Healthcare Facilities